4.3(top 10%)
impact factor
5.0K(top 5%)
papers
84.0K(top 5%)
citations
93(top 5%)
h-index
4.4(top 10%)
impact factor
6.0K
all documents
93.4K
doc citations
144(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Vaccine hesitancyHuman Vaccines and Immunotherapeutics20131,419
2Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseasesHuman Vaccines and Immunotherapeutics2020722
3The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to payHuman Vaccines and Immunotherapeutics2020582
4COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional surveyHuman Vaccines and Immunotherapeutics2021517
5COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeuticsHuman Vaccines and Immunotherapeutics2020444
6Measuring trust in vaccination: A systematic reviewHuman Vaccines and Immunotherapeutics2018434
7The success of microneedle-mediated vaccine delivery into skinHuman Vaccines and Immunotherapeutics2016370
8The rationale for quadrivalent influenza vaccinesHuman Vaccines and Immunotherapeutics2012325
9PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerationsHuman Vaccines and Immunotherapeutics2019297
10Advances in aluminum hydroxide-based adjuvant research and its mechanismHuman Vaccines and Immunotherapeutics2015293
11Talimogene laherparepvec: First in class oncolytic virotherapyHuman Vaccines and Immunotherapeutics2018247
12Mechanisms and pathways of innate immune activation and regulation in health and cancerHuman Vaccines and Immunotherapeutics2014246
13Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virusHuman Vaccines and Immunotherapeutics2016243
14Pembrolizumab (Keytruda)Human Vaccines and Immunotherapeutics2016237
15RTS,S/AS01 vaccine (Mosquirix™): an overviewHuman Vaccines and Immunotherapeutics2020232
16COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safetyHuman Vaccines and Immunotherapeutics2022231
17Provider communication about HPV vaccination: A systematic reviewHuman Vaccines and Immunotherapeutics2016220
18Polymeric nanoparticlesHuman Vaccines and Immunotherapeutics2014219
19Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccineHuman Vaccines and Immunotherapeutics2014207
20Transforming growth factor-β: A therapeutic target for cancerHuman Vaccines and Immunotherapeutics2017206
21Adjuvanted influenza vaccinesHuman Vaccines and Immunotherapeutics2018206
22A review of Dengvaxia®: development to deploymentHuman Vaccines and Immunotherapeutics2019206
23Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literatureHuman Vaccines and Immunotherapeutics2018202
24Epidemiology of vaccine hesitancy in the United StatesHuman Vaccines and Immunotherapeutics2013200
25DNA vaccine for cancer immunotherapyHuman Vaccines and Immunotherapeutics2014198
26Japanese encephalitisHuman Vaccines and Immunotherapeutics2014196
27Pre-existing immunity against Ad vectorsHuman Vaccines and Immunotherapeutics2014195
28Tocilizumab (Actemra)Human Vaccines and Immunotherapeutics2017193
29Protein carriers of conjugate vaccines: Characteristics, development and clinical trialsHuman Vaccines and Immunotherapeutics2013185
30PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicityHuman Vaccines and Immunotherapeutics2016184
31Recent progress in adjuvant discovery for peptide-based subunit vaccinesHuman Vaccines and Immunotherapeutics2014183
32Story and scienceHuman Vaccines and Immunotherapeutics2013181
33The rise (and fall?) of parental vaccine hesitancyHuman Vaccines and Immunotherapeutics2013179
34Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?Human Vaccines and Immunotherapeutics2022176
35Comparison of HDAC inhibitors in clinical developmentHuman Vaccines and Immunotherapeutics2013173
36Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the futureHuman Vaccines and Immunotherapeutics2013173
37Phage display—A powerful technique for immunotherapyHuman Vaccines and Immunotherapeutics2012171
38A novel, disruptive vaccination technologyHuman Vaccines and Immunotherapeutics2013171
39Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccineHuman Vaccines and Immunotherapeutics2012168
40Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicityHuman Vaccines and Immunotherapeutics2017168
41HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in EuropeHuman Vaccines and Immunotherapeutics2019168
42Assessing COVID-19 vaccine literacy: a preliminary online surveyHuman Vaccines and Immunotherapeutics2021168
43A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacistsHuman Vaccines and Immunotherapeutics2022167
44Health literacy and vaccination: A systematic reviewHuman Vaccines and Immunotherapeutics2018166
45Vaccines and routine immunization strategies during the COVID-19 pandemicHuman Vaccines and Immunotherapeutics2021165
46Vaccines against invasiveSalmonelladiseaseHuman Vaccines and Immunotherapeutics2014163
47Peptide/protein vaccine delivery system based on PLGA particlesHuman Vaccines and Immunotherapeutics2016163
48The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic reviewHuman Vaccines and Immunotherapeutics2022163
49From discovery to licensure, the Adjuvant System storyHuman Vaccines and Immunotherapeutics2017160
50Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccinesHuman Vaccines and Immunotherapeutics2013157